Zimmer Biomet Holdings Inc

Healthcare · Medical Devices

89.70$ -1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Zimmer Biomet Holdings Inc (ZBH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,177 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZBH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,833	2,013	1,972	1,950	1,813	2,074	2,018	2,008	1,837	2,071	1,976	1,989	1,892	2,126	1,784	1,226	1,929	2,085	1,601	1,763	1,685	2,038	1,663	1,782	1,670	1,825	1,831	1,870	1,754	1,940	1,889	1,942	1,824	2,023	1,909	2,077	2,001	2,244	2,087	2,177	8,509
Cost of Revenue	479	622	513	528	501	591	576	584	529	583	553	581	536	582	487	425	569	647	436	496	491	662	500	511	488	520	501	526	519	539	512	554	539	587	550	592	559	792	576	636	2,563
Gross Profit	1,354	1,391	1,460	1,422	1,312	1,483	1,442	1,424	1,308	1,488	1,422	1,407	1,357	1,544	1,297	802	1,360	1,438	1,165	1,267	1,194	1,376	1,163	1,271	1,182	1,305	1,330	1,344	1,235	1,401	1,377	1,388	1,286	1,437	1,359	1,485	1,442	1,451	1,511	1,542	5,946
Research & Development	96	96	91	93	91	95	96	99	96	101	102	112	114	121	98	88	86	100	81	165	94	113	97	99	102	108	110	118	117	113	108	109	112	109	111	113	116	119	103	105	443
Selling, General & Administrative	831	1,107	849	752	795	879	802	791	788	2,449	796	840	826	1,637	829	665	790	894	0.8	817	802	817	685	695	655	727	716	726	675	722	736	737	710	747	759	815	811	856	850	899	3,416
Total Operating Expenses	1,158	1,208	1,111	1,142	1,101	1,521	1,137	1,128	1,084	2,278	1,072	1,203	1,111	1,207	1,753	973	1,061	1,197	906	1,042	951	1,297	965	990	936	1,333	1,003	1,015	968	1,047	1,111	1,037	1,006	1,048	1,067	1,185	1,091	1,164	1,137	1,215	4,607
Operating Income	196	183	348	280	211	-38	305	296	223	-791	350	205	246	337	-456	-172	299	241	259	225	243	79	198	281	245	-28	327	330	267	354	266	351	280	389	292	300	351	288	373	326	1,338
Interest Expense	92	90	83	82	82	80	78	75	68	66	58	60	57	52	51	54	54	53	52	55	53	49	41	39	42	43	48	52	51	50	51	51	54	62	66	79	75	72	69	73	289
Pre-Tax Income	104	31	265	196	127	-124	223	218	154	-866	292	140	185	289	-504	-222	256	196	214	178	191	-139	101	200	178	-75	287	277	219	285	215	302	230	289	229	225	279	98	301	255	934
Income Tax Expense	-54	-39	-34	12	28	-1,355	47	33	-8.5	37	46	8.4	-247	-32	5.2	-14	9.7	-138	21	33	28	-55	28	46	-17	55	54	67	56	-135	42	59	-19	49	47	71	48	-40	63	56	127
Net Income	159	70	299	184	99	1,231	175	185	162	-901	246	134	431	321	-509	-207	243	334	198	142	146	-84	14	154	194	-131	233	210	163	419	172	243	249	240	182	153	231	140	238	198	807
EBITDA	483	373	616	543	476	220	565	555	482	-545	597	453	493	596	-200	88	568	514	502	469	476	177	376	471	451	196	567	566	512	576	504	597	536	615	550	576	638	454	538	328	1,958

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings